Monday, October 13, 2025
Home Authors Posts by Ogkologos

Ogkologos

4035 POSTS 0 COMMENTS

Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for...

Ogkologos -
0

FDA Approves Pembrolizumab for HER2 Positive Gastric or Gastro-oesophageal Junction Adenocarcinoma...

Ogkologos -
0

Expanding Research on Dormant Cancer Cells Aims to Prevent Metastasis

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Linvoseltamab

Ogkologos -
0

Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients...

Ogkologos -
0

Adding One Year of Palbociclib to Adjuvant Endocrine Treatment Does Not...

Ogkologos -
0

Adding Chemotherapy to Radiotherapy Not Associated with Improved OS for Patients...

Ogkologos -
0

FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumour

Ogkologos -
0

EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment...

Ogkologos -
0

Plasma-Based, Tumour-Informed MRD Analysis May Predict Recurrence During Adjuvant Osimertinib and...

Ogkologos -
0
1...161718...404Page 17 of 404

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com